Posted 6 months ago ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation (ORACLE) ClinicalTrials.gov ID NCT05059444 Protocol number 02-MX-003 Sponsor Guardant Health, Inc.
